<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03741569</url>
  </required_header>
  <id_info>
    <org_study_id>2017_63</org_study_id>
    <secondary_id>2018-A01194-51</secondary_id>
    <nct_id>NCT03741569</nct_id>
  </id_info>
  <brief_title>Multisensor Technology for Beat to Beat Fetal Heart Rate Measurement</brief_title>
  <acronym>RCF-ABDO</acronym>
  <official_title>Development of a Real-time Signal Processing Algorithm, for Beat-beat Measurement of Fetal Heart Rate and Uterine Contractions by Coupling Non-invasive ABDOminal Sensors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The CIC-IT 1403 laboratory of the University Hospital of Lille has developed a technological&#xD;
      solution for acquiring and synchronizing abdominal ECG, acoustic and Doppler signals.&#xD;
&#xD;
      The purpose of this clinical trial is to build a database of signals issued from this device&#xD;
      to develop signal processing algorithms to allow optimization of the fetal heart rate&#xD;
      calculation.&#xD;
&#xD;
      This study will be carried out in the maternity ward of the Jeanne de Flandre Hospital in the&#xD;
      maternal-fetal pathology department Doppler, ECG and acoustic sensors will be placed on the&#xD;
      mother's abdomen to capture the heart rate of the fetus and mother as well as uterine&#xD;
      contractions.&#xD;
&#xD;
      For each of the participants, we will make two 15-minute recordings: one with conventional&#xD;
      ECG electrodes and one with ECG textile electrodes.&#xD;
&#xD;
      This procedure will not affect the usual care of the patient&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 17, 2017</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The fetal heart rate signal</measure>
    <time_frame>at 15 minutes</time_frame>
    <description>The fetal heart rate signal extraction algorithm will be based on the various signal processing tools developed by the INSERM CIC-IT 1403 laboratory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The uterine contraction signal</measure>
    <time_frame>at 15 minutes</time_frame>
    <description>The uterine contraction signal extraction algorithm will be based on the different signal processing tools developed by the INSERM CIC-IT 1403 laboratory.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measuring the root mean square deviation between the heart rate signals from the device and the Doppler</measure>
    <time_frame>at 15 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Obstetric Labor</condition>
  <arm_group>
    <arm_group_label>parturients (gestational age ≥37 weeks).</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transabdominal Fetal Heart Rate</intervention_name>
    <description>Doppler, ECG and acoustic sensors will be placed on the mother's abdomen to capture the heart rate of the fetus and mother as well as uterine contractions.&#xD;
For each of the participants, we will make two 15-minute recordings: one with conventional ECG electrodes and one with ECG textile electrodes</description>
    <arm_group_label>parturients (gestational age ≥37 weeks).</arm_group_label>
    <other_name>Fetal heart rate recording</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Age&gt;18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple pregnancy&#xD;
&#xD;
          -  Medical termination of pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant woman</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Garrabedian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>charles Garrabedian, MD</last_name>
    <phone>03 20 44 66 26</phone>
    <phone_ext>+33</phone_ext>
    <email>charles.garabedian@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Roger Salengro, CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Charles Garabedian, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 12, 2018</study_first_submitted>
  <study_first_submitted_qc>November 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2018</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fetal heart rate</keyword>
  <keyword>Multiple sensors</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

